🇪🇺 fesoterodine 4mg in European Union

EMA authorised fesoterodine 4mg on 20 April 2007

Marketing authorisation

EMA — authorised 20 April 2007

  • Application: EMEA/H/C/000723
  • Marketing authorisation holder: Pfizer Europe MA EEIG
  • Local brand name: Toviaz
  • Indication: Treatment of the symptoms (increased urinary frequency and / or urgency and / or urgency incontinence) that may occur in patients with overactive-bladder syndrome.
  • Status: approved

Read official source →

fesoterodine 4mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is fesoterodine 4mg approved in European Union?

Yes. EMA authorised it on 20 April 2007.

Who is the marketing authorisation holder for fesoterodine 4mg in European Union?

Pfizer Europe MA EEIG holds the EU marketing authorisation.